Where does MED ET AL., Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), MED ET AL., Inc. ranks #48,628 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does MED ET AL., Inc. hold?

MED ET AL., Inc. holds 5 US utility patents granted between 2015 and 2022, spanning 5 technology areas.

What is MED ET AL., Inc.'s Innovation Score?

MED ET AL., Inc. has an Innovation Score of 22.6 out of 100 (11th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is MED ET AL., Inc.'s patent grant rate increasing or decreasing?

MED ET AL., Inc.'s recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for MED ET AL., Inc.'s patents?

MED ET AL., Inc.'s patents average 8.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the MED ET AL., Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

MED ET AL., Inc.

Q: What technology areas does MED ET AL., Inc. focus on?

MED ET AL., Inc.'s top technology area is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle) with 1 patents, ranking #547 of 903 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, MED ranks #48,628 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.

#48,628
of 49,997 US assignees by volume: 11th percentile
by Innovation Score (22.6/100): 8.6
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R48628 · US Corporation #48,628 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #48,628/49,997
PHOTO-FINISH Meas Deutschland
CPC-NARROW A61J · 5 areas
INNOV-THIN 22.6/100
CLAIMS-PAR 8.6 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Meas Deutschland GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How MED’s 22.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (27%) Velocity 3.3 pts (15%) Breadth 7.9 pts (35%) Claim depth 5.2 pts (23%)

Qualcomm Incorporated · highest

85
MED ET AL · this assignee

23
3D Lighting… · lowest

7

What this shows MED's Innovation Score is 22.6/100 (11th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for MED?

Each dot is one of MED’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). MED’s own 8.6 claims/patent is at or below the 10.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

MED vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where MED's grants concentrate

MED ET AL., Inc. is a focused PatentsView assignee: 5 CPC subclasses with 20% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). By volume, MED sits between Meas Deutschland GmbH and Media Network Services AS.

MED's three-year grant acceleration

MED ET AL., Inc. shows 1 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Meas Deutschland

5
Meaty Meats

5
Mecatherm

5
Mechanical Softwa…

5
Mederer

5
Medesis Pharma

5
Medi Futures

5
Media Network Ser…

5
MED ET AL ◀

5

What this shows MED holds 5 patents at rank #48,578, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near MED

By rank, the assignees closest to #48,578 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in MED's primary technology class.

MED's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

23 11th percentile higher than 11% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

MED ET AL., Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	20.0%
2018	1	20.0%
2019	1	20.0%
2020	1	20.0%
2022	1	20.0%

Which technologies does MED ET AL., Inc. patent most?

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

G06F - Electric Digital Data Processing 1

A63F - Card, Board, OR Roulette GAMES; Indoor Games Using Small Moving Playing BODIES; Video GAMES; Games NOT Otherwise Provided FOR 1

G09G - Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information 1

A63H - Toys, e.g. Tops, Dolls, Hoops OR Building Blocks 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

MED ET AL., Inc.'s patent record in context - here's where to go next.

MED ET AL., Inc.'s lead technology class is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ), 20% of its portfolio - see every assignee active in that class. Explore A61J
Ranked #48,628 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare MED ET AL., Inc. against Meas Deutschland GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 22.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.